Aerie pharmaceuticals, inc. (AERI)
Income statement / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Sep'12
Total revenues, net

79,377

69,888

59,687

48,445

35,033

24,181

9,725

2,423

0

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Costs and expenses:
Cost of goods sold

10,544

4,833

3,526

1,668

1,022

641

264

59

0

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Costs and expenses:
Selling, general and administrative

139,022

138,402

134,822

135,336

133,966

120,614

94,230

81,319

65,360

56,905

56,294

47,147

39,380

34,706

37,462

34,297

32,413

30,635

29,367

26,849

24,514

20,103

17,317

15,660

12,433

10,287

8,109

0

0

0

Pre-approval commercial manufacturing

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Pre-approval commercial manufacturing

-

-

23,742

25,149

-

26,545

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Research and development

92,667

91,378

87,076

93,782

91,035

86,123

97,732

81,638

74,096

72,078

48,070

48,350

51,039

52,394

50,603

47,819

45,142

44,451

41,742

40,068

36,117

29,869

23,432

17,601

14,098

11,883

10,100

0

0

0

Total costs and expenses

262,657

257,380

249,166

255,935

252,132

233,923

227,856

191,398

161,059

145,693

108,694

99,202

0

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss from operations

-183,280

-187,492

-189,479

-207,490

-217,099

-209,742

-218,131

-188,975

-161,059

-145,693

-114,136

-105,269

-100,191

-96,872

-88,065

-82,116

-77,555

-75,086

-71,109

-66,917

-60,631

-49,972

-40,749

-33,261

-26,531

-22,170

-18,209

0

0

0

Other (expense) income, net

-17,512

-12,179

-6,586

-24,561

-22,809

-22,824

-23,390

519

-762

-1,170

-1,575

-1,894

-1,758

-1,994

-2,002

-2,065

-2,088

862

846

1,396

1,930

1,839

-1,165

-6,254

-7,498

-8,978

-6,249

0

0

0

Loss before income taxes

-200,792

-199,671

-196,065

-232,051

-239,908

-232,566

-241,521

-188,456

-161,821

-146,863

-115,711

-107,163

-101,949

-98,866

-90,067

-84,181

-79,643

-74,224

-66,909

-60,834

0

-

0

0

-

-

-

-

-

-

Income tax (benefit) expense

-33

-90

-90

-90

-87

3

-1,897

-1,848

-1,804

-1,758

203

193

193

193

47

80

185

139

224

152

0

-

0

0

-

-

-

-

-

-

Net loss

-200,759

-199,581

-195,975

-231,961

-239,821

-232,569

-239,624

-186,608

-160,017

-145,105

-115,914

-107,356

-102,142

-99,059

-90,114

-84,261

-79,828

-74,363

-70,487

-65,673

-58,701

-48,133

-41,914

-39,515

-34,029

-31,148

-24,458

0

0

0

Net loss attributable to common stockholdersbasic and diluted

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-79,828

-

-70,487

-65,673

-58,701

-48,133

-41,951

-39,691

-34,342

-31,598

-25,009

0

0

0

Net loss per common share—basic and diluted (in dollars per share)

-1.07

-1.20

-1.09

-1.04

-1.06

-1.17

-1.96

-1.40

-1.05

-1.64

-0.89

-0.82

-0.76

-0.87

-0.81

-0.87

-0.85

-0.76

-0.69

-0.73

-0.70

-0.69

-0.54

-0.49

-0.28

15.09

-10.81

-6.59

-4.07

-3.87

Weighted average number of common shares outstanding—basic and diluted (in shares)

45,792

45,592

45,448

45,397

45,270

45,194

43,657

39,204

38,598

36,526

36,210

34,783

33,777

33,665

29,380

26,773

26,723

26,618

26,061

25,841

24,602

24,410

24,325

23,893

23,717

16,869

1,006

981

965

964

Net loss

-200,759

-199,581

-195,975

-231,961

-239,821

-232,569

-239,624

-186,608

-160,017

-145,105

-115,914

-107,356

-102,142

-99,059

-90,114

-84,261

-79,828

-74,363

-70,487

-65,673

-58,701

-48,133

-41,914

-39,515

-34,029

-31,148

-24,458

0

0

0

Unrealized (loss) gain on available-for-sale investments

-120

-92

-157

9

157

28

97

72

-52

40

-85

-71

-37

111

19

31

-10

-72

-23

-28

-37

-107

0

0

0

-

-

-

-

-

Comprehensive loss

-200,879

-199,673

-196,132

-231,952

-239,664

-232,541

-239,527

-186,536

-160,069

-145,065

-115,999

-107,427

-102,179

-98,948

-90,095

-84,230

-79,838

-74,435

-70,510

-65,701

-58,738

-48,240

-41,923

-39,528

-34,050

-31,148

-24,458

0

0

0

Product revenues, net
Total revenues, net

79,377

69,888

59,687

48,445

35,033

24,181

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-